Skip to main content

Table 4 Multivariate analysis for overall survival

From: Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients’ quality of life

 

HR (95% CI)

P value

Treatment with GEM

0.34 (0.20–0.57)

0.0001a

Age <70

1.09 (0.68–1.77)

0.7104

Male

0.89 (0.53–1.48)

0.6490

T factor ≦T2

0.49 (0.25–0.94)

0.0314a

N factor N0

0.75 (0.26–2.19)

0.6046

UICC stage ≦VIIA

1.23 (0.36–4.26)

0.7415

Resection status R0

0.38 (0.20–0.73)

0.0033a

  1. aStatistically significant difference.
  2. CI confidence interval; GEM gemcitabine; HR hazard ratio.
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us